Please assess the completion status of the following clinical trial:

Trial Title: Collagen Cross-Linking With Ultraviolet-A in Asymmetric Corneas

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE2
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* A diagnosis of at least one of the following conditions:~  1. Keratoconus~ 2. Forme fruste keratoconus~ 3. Post-LASIK ectasia~ 4. Pellucid marginal degeneration~ 5. Forme fruste pellucid marginal degeneration~ 6. Diurnal fluctuation post-radial keratotomy~ 7. Terrien's marginal degeneration~Exclusion Criteria:~1. Corneal thickness \< 375 microns measured by ultrasound or Pentacam.~2. Contraindications or hypersensitivities to any study medications or their components.~3. Pregnancy or breastfeeding.~4. Any history of herpes simplex corneal disease in an eye to be treated.~5. Nystagmus or any other condition that would, in the judgement of the investigator, prevent a steady gaze during the treatment.~6. Inability to cooperate with diagnostic tests.~7. Enrollment in another ophthalmic clinical trial.

- Gender: ALL
- Minimum Age: 8 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Group 1 (Type: ACTIVE_COMPARATOR): Ultraviolet-A (UVA)-induced cross-linking of corneal collagen (CXL) using CXLO Corneal Strengthening Solution and a UVA irradiance of 4 mW/cm2 cycled On/Off at 15 second intervals for 20 minutes.
- Group 2 (Type: ACTIVE_COMPARATOR): Ultraviolet-A (UVA)-induced cross-linking of corneal collagen (CXL) using CXLO Corneal Strengthening Solution and a UVA irradiance of 6 mW/cm2 cycled On/Off at 15 second intervals for 20 minutes.
- Group 3 (Type: ACTIVE_COMPARATOR): Ultraviolet-A (UVA)-induced cross-linking of corneal collagen (CXL) using CXLO Corneal Strengthening Solution and a UVA irradiance of 4 mW/cm2 cycled On/Off at 15 second intervals for 30 minutes.

Based on this trial design, predict the completion outcome and termination type (if applicable).